Repligen Corporation (NasdaqGS:RGEN) entered into a definitive agreement to acquire Metenova AB for $173 million on September 26, 2023. The transaction is a combination of cash and equity; to fund the cash component of the transaction, Repligen intends to use a portion of its cash on hand, which totaled approximately $604 million at June 30, 2023. The transaction is expected to be completed in the coming weeks, subject to the satisfaction of customary closing conditions. Perella Weinberg Partners (NasdaqGS:PWP) acted as financial advisor to Repligen Corporation (NasdaqGS:RGEN). Advokatfirman Vinge KB and Goodwin Procter LLP acted as legal advisor to Repligen Corporation (NasdaqGS:RGEN). J.P. Morgan Securities plc acted as financial advisor and Setterwalls Advokatbyrå Ab acted as legal advisor to Metenova AB. Acquisition of Metenova AB was done at a purchase price of $164 million in cash and $9 million in equity consideration.

Repligen Corporation (NasdaqGS:RGEN) completed the acquisition of Metenova AB on October 2, 2023.